Dupuytren disease is a benign, progressive fibroproliferative disorder of the hands. To date,
only one pharmacotherapy (clostridial collagenase) has been approved for use in …

Methods A systematic literature review was performed to identify all relevant data. The
examined databases were Scopus, Web of Science, Cochrane, Google Scholar, and …

In pilot work, we showed that somatic nerve transfers can restore motor function in long-term
decentralized dogs. We continue to explore the effectiveness of motor reinnervation in 30 …

Post-COVID-19 pulmonary fibrosis (PCPF) is a long-term complication that appears in some
COVID-19 survivors. However, there are currently limited options for treating PCPF patients …

Systemic sclerosis (SSc) is a devastating autoimmune illness with a wide range of clinical
symptoms, including vascular abnormalities, inflammation, and persistent and progressive …

Dupuytren disease is a progressive, benign fibroproliferative disorder of the hands that can
lead to debilitating hand contractures. Once symptomatic, treatment involves either surgical …

Idiopathic pulmonary fibrosis (IPF) is a life-threatening disease with a survival rate of< 5
years. The TGF-β plays a significant role in the progression and severity of IPF. The TGF-β …

Dupuytren's disease is a progressive, benign fibroproliferative disorder of the hands that can
lead to debilitating hand contractures. Once symptomatic, treatment involves either surgical …

Systemic sclerosis, also known as scleroderma or SSc, is a condition characterized by
significant heterogeneity in clinical presentation, disease progression, and response to …